FDA 510(k)
FDA class 2
Substantially Equivalent
🇩🇪 Germany
N Latex FLC kappa, N Latex FLC lambda
K Number: K212379
·
Decision Mar 2, 2022
Classifications
1
FEI Numbers
17
Registration Numbers
17
Same Product Code
61
Applicant Total
16
Review Days
212
Basic Information
- Device Name
- N Latex FLC kappa, N Latex FLC lambda
- K Number
- K212379
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5550
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Siemens Healthcare Diagnostics Products GmbH
- Date Received
- August 2, 2021
- Decision Date
- March 2, 2022
- Product Code
- DFH
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DFH | Kappa, Antigen, Antiserum, Control | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DFH), ordered by most recent decision date.
Optilite® Freelite Mx Kappa Free Kit; Optilite® Freelite Mx Lambda Free Kit
FDA 510(k)
FDA Class 2
·Immunology
FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2
FDA 510(k)
FDA Class 2
·Immunology
Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free Kit
FDA 510(k)
FDA Class 2
·Immunology
FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2
FDA 510(k)
FDA Class 2
·Immunology
Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay
FDA 510(k)
FDA Class 2
·Immunology
Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Siemens Healthcare Diagnostics Products GmbH
| K Number | Device Name | ||
|---|---|---|---|
| K240315 | INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05) | Oct 10, 2024 | Substantially Equivalent |
| K233663 | N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) | Dec 13, 2023 | Substantially Equivalent |
| K220728 | vWF Ag | Jun 2, 2023 | Substantially Equivalent |
| K212559 | CardioPhase® hsCRP | Dec 16, 2022 | Substantially Equivalent |
| DEN200067 | INNOVANCE VWF Ac | Sep 29, 2022 | Unknown |
| K201496 | N Latex FLC kappa, N Latex FLC lambda | Oct 29, 2021 | Substantially Equivalent |
| K193047 | N Latex FLC kappa, N Latex FLC lambda | Jul 14, 2021 | Substantially Equivalent |
| K190879 | N Latex FLC kappa, N Latex FLC lambda | May 3, 2019 | Substantially Equivalent |
| K182098 | N Latex FLC kappa assay, N Latex FLC lambda assay | Nov 1, 2018 | Substantially Equivalent |
| K181525 | INNOVANCE Free PS Ag | Sep 7, 2018 | Substantially Equivalent |